» Articles » PMID: 38399766

From Viral Infection to Autoimmune Reaction: Exploring the Link Between Human Herpesvirus 6 and Autoimmune Diseases

Overview
Journal Microorganisms
Specialty Microbiology
Date 2024 Feb 24
PMID 38399766
Authors
Affiliations
Soon will be listed here.
Abstract

The complexity of autoimmunity initiation has been the subject of many studies. Both genetic and environmental factors are essential in autoimmunity development. Among others, environmental factors include infectious agents. HHV-6 is a ubiquitous human pathogen with a high global prevalence. It has several properties suggestive of its contribution to autoimmunity development. HHV-6 has a broad cell tropism, the ability to establish latency with subsequent reactivation and persistence, and a range of immunomodulation capabilities. Studies have implicated HHV-6 in a plethora of autoimmune diseases-endocrine, neurological, connective tissue, and others-with some studies even proposing possible autoimmunity induction mechanisms. HHV-6 can be frequently found in autoimmunity-affected tissues and lesions; it has been found to infect autoimmune-pathology-relevant cells and influence immune responses and signaling. This review highlights some of the most well-known autoimmune conditions to which HHV-6 has been linked, like multiple sclerosis and autoimmune thyroiditis, and summarizes the data on HHV-6 involvement in autoimmunity development.

Citing Articles

Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders.

Sivalingam A Clin Rev Allergy Immunol. 2025; 68(1):14.

PMID: 39932617 DOI: 10.1007/s12016-025-09022-9.

References
1.
Ablashi D, Eastman H, Owen C, Roman M, Friedman J, Zabriskie J . Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000; 16(3):179-91. DOI: 10.1016/s1386-6532(99)00079-7. View

2.
Gravelsina S, Vilmane A, Svirskis S, Rasa-Dzelzkaleja S, Nora-Krukle Z, Vecvagare K . Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome. Front Immunol. 2022; 13:928945. PMC: 9589447. DOI: 10.3389/fimmu.2022.928945. View

3.
Broccolo F, Drago F, Cassina G, Fava A, Fusetti L, Matteoli B . Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases. J Med Virol. 2013; 85(11):1925-34. DOI: 10.1002/jmv.23670. View

4.
Riverol M, Sepulcre J, Fernandez-Diez B, Villoslada P, Fernandez-Alonso M, Rubio M . Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of multiple sclerosis. J Neuroimmunol. 2007; 192(1-2):184-5. DOI: 10.1016/j.jneuroim.2007.08.010. View

5.
Behzad-Behbahani A, Mikaeili M, Entezam M, Mojiri A, Pour G, Arasteh M . Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis. J Microbiol Immunol Infect. 2011; 44(4):247-51. DOI: 10.1016/j.jmii.2010.08.002. View